Menu

Blog

Page 3834

Jun 7, 2022

How engineers and drug developers are working to change childhood cancer’s deadly calculus

Posted by in categories: biotech/medical, engineering

A non-profit organization merges engineering and biology to accelerate drug development for childhood cancers.

Jun 7, 2022

Fixing Spinal Cord Injuries With ‘Dancing Molecules’

Posted by in category: futurism

Summary: A new injectable therapy that uses specially engineered molecules could help treat spinal cord injury.

Source: DOE

A new injectable therapy for spinal cord injuries uses specially engineered molecules that trigger a healing response in spinal cells.

Jun 7, 2022

Musk will drop Twitter deal if data on bots not provided

Posted by in categories: cybercrime/malcode, Elon Musk, law, robotics/AI

In a new letter, Elon Musk threatens to walk away from $44 Billion Twitter deal if the management doesn’t provide more data on total bot counts.

According to a letter sent by Elon Musk’s legal team to Twitter, “Twitter refused to provide the information that Mr. Musk has repeatedly requested since May 9, 2022 to facilitate his evaluation of spam and fake accounts on the company’s platform” and “It’s effort to characterize it otherwise is merely an attempt to obfuscate and confuse the issue”.

The letter also reminded that Musk does not believe the company’s lax testing methodologies are adequate so he must conduct his own analysis and “The data he has requested is necessary to do so”. The letter also said “Mr. Musk is entitled to seek, and Twitter is obligated to provide information and data”.

Jun 7, 2022

Scientists Discover That the Human Brain Works in 11 Dimensions

Posted by in categories: computing, neuroscience, sustainability

A group of photonics researchers at Tampere University have introduced a novel method to control a light beam with another beam through a unique plasmonic metasurface in a linear medium at ultra-low power. This simple linear switching method makes nanophotonic devices such as optical computing and communication systems more sustainable, requiring low intensity of light.

Jun 7, 2022

A novel all-optical switching method makes optical computing and communication systems more power-efficient

Posted by in categories: computing, quantum physics, sustainability

A group of photonics researchers at Tampere University have introduced a novel method to control a light beam with another beam through a unique plasmonic metasurface in a linear medium at ultra-low power. This simple linear switching method makes nanophotonic devices such as optical computing and communication systems more sustainable, requiring low intensity of light.

All– is the modulation of signal light due to control light in such a way that it possesses the on/off conversion function. In general, a can be modulated with another intense laser beam in the presence of a nonlinear medium.

The switching method developed by the researchers is fundamentally based on the quantum optical phenomenon known as Enhancement of Index of Refraction (EIR).

Jun 7, 2022

Diabetes drug helps patients lose never-before-seen amounts of weight, study shows

Posted by in category: biotech/medical

A study of the Type 2 diabetes drug tirzepatide found it resulted in dramatic weight loss, offering hope for those struggling with obesity.

Jun 7, 2022

Musk accuses Twitter of ‘resisting and thwarting’ his right to information on fake accounts

Posted by in categories: Elon Musk, materials

Elon Musk accused Twitter of “resisting and thwarting” his right to information about fake accounts on the platform, calling it in a letter to the company on Monday a “clear material breach” of the terms of their merger agreement.

“Mr. Musk reserves all rights resulting therefrom, including his right not to consummate the transaction and his right to terminate the merger agreement,” the letter, signed by Skadden Arps attorney Mike Ringler, says.

Twitter shares were down 5% on Monday morning.

Jun 7, 2022

Drug combination shows promise against cancer’s ‘death star’ protein

Posted by in categories: biotech/medical, genetics

A drug combination targeting multiple mutant versions of cancer’s “death star” protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer.

The two– was effective against with a range of mutations to the KRAS gene—dubbed the “death star” because its protein drives one in four cancers and has a largely impenetrable, drug-resistant surface.

The phase I trial tested the drugs VS-6766 and everolimus in 30 patients with a range of mutations to KRAS—including 11 with highly advanced, .

Jun 7, 2022

Tesla could have a working humanoid robot

Posted by in categories: Elon Musk, robotics/AI

Jun 7, 2022

Pantuo Aviation reveals the first footage of its prototype flying taxi

Posted by in category: transportation